Sedat, designer and manufacturer of plastic injection-moulded drug delivery devices, has selected EASTMAN CHEMICAL COMPANY’s new grade MN058 of Eastar for an innovative angiographic syringe that has achieved a technological breakthrough in the medical sector.
Designed to operate in conjunction with a new type of injector that controls the delivery of a contrast medium into the patient’s blood system, Sedat’s ELS 200 ml angiographic syringe is an innovation both in concept and performance. Based on a sole partnership agreement with Medtron of Saarbrücken (Germany) who manufactures the injector, Sedat is the sole producer of this type of syringe in Europe. The ELS (Easy Loading System) uses a new patented concept for the fitting with the injector and relies on Eastman’s new grade MN058 of Eastar.
In comparison with the previous state-of-the-art syringe moulded in polypropylene, it can be fitted to the injector by simply sliding it into a holding sleeve and locking it in position instead of the three to four fitting steps previously required.
